Dana Investment Advisors, Inc. Amgen Inc Transaction History

Dana Investment Advisors, Inc.

$2.93 Billion
Q2 2024

A detailed history of Dana Investment Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Dana Investment Advisors, Inc. holds 1,454 shares of AMGN stock, worth $459,464. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,454

Previous 1,454 -0.0%

Holding current value

$459,464

Previous $454,000 -0.0%

% of portfolio

0.02%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $10,510 - $12,772	-40 Reduced 2.68%	1,454 $454,000
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $59,151 - $71,403	220 Added 17.27%	1,494 $424,000
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $105,604 - $119,133	-413 Reduced 24.48%	1,274 $366,000
Q3 2023 Nov 15, 2023	SELL	$218.65 - $271.46 $9,839 - $12,215	-45 Reduced 2.6%	1,687 $453,000
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $41,319 - $50,361	-183 Reduced 9.56%	1,732 $418,000
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $169,253 - $215,056	739 Added 62.84%	1,915 $502,000
Q3 2022 Nov 15, 2022	SELL	$224.46 - $253.15 $119,861 - $135,182	-534 Reduced 31.23%	1,176 $265,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $104,511 - $116,303	453 Added 36.04%	1,710 $416,000
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $1,988 - $2,276	10 Added 0.8%	1,257 $283,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $19,741 - $23,129	93 Added 8.06%	1,247 $265,000
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $82,687 - $91,735	-354 Reduced 23.47%	1,154 $281,000
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $15.9 Million - $18.5 Million	-71,512 Reduced 97.93%	1,508 $375,000
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $2.95 Million - $3.51 Million	-13,619 Reduced 15.72%	73,020 $16.8 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $1.58 Million - $1.75 Million	-6,725 Reduced 7.2%	86,639 $22 Million
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $2.82 Million - $3.46 Million	-14,254 Reduced 13.24%	93,364 $22 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $1.85 Million - $2.46 Million	-10,173 Reduced 8.64%	107,618 $21.8 Million
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $338,685 - $435,328	1,790 Added 1.54%	117,791 $28.4 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $454,252 - $544,289	-2,609 Reduced 2.2%	116,001 $22.4 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $836,667 - $980,762	-5,019 Reduced 4.06%	118,610 $21.9 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $1.98 Million - $2.24 Million	-10,969 Reduced 8.15%	123,629 $23.5 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $3.37 Million - $3.93 Million	-18,888 Reduced 12.31%	134,598 $26.2 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $571,063 - $643,798	3,082 Added 2.05%	153,486 $31.8 Million
Q2 2018 Aug 01, 2018	BUY	$166.05 - $186.51 $1.4 Million - $1.58 Million	8,452 Added 5.95%	150,404 $0
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $3.46 Million - $4.05 Million	-20,438 Reduced 12.59%	141,952 $24.2 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $355,302 - $396,981	-2,105 Reduced 1.28%	162,390 $0
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $27.5 Million - $31.4 Million	164,495	164,495 $30.7 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dana Investment Advisors, Inc. with notifications on news.

Account

Dana Investment Advisors, Inc. Amgen Inc Transaction History